The FDA has granted accelerated approval of Wegovy® (semaglutide) for adults with moderate to advanced metabolic ...

With results from highly anticipated trials of Eli Lilly’s orforglipron and Viking Therapeutics’ VK2735 “underwhelming” ...

Novo Nordisk announced it is cutting ties with telehealth giant Hims & Hers Health, pulling its blockbuster drug Wegovy from ...

Miriam Margolyes said that she’s let her body down as she continues to deal with multiple health conditions. The Harry Potter ...

Through innovation, cost discipline, legal action, and competitive pricing, Novo Nordisk has reasserted its leadership in the GLP-1 market. With a robust pipeline and global expansion, NVO is poised ...

Eli Lilly and Company LLY is a key player in the diabetes and obesity drug market, mainly due to the significant popularity ...

Serena Williams has long been subjected to ill-tasted criticism over her weight. Her recent collaboration with a healthy ...

Imagine losing weight effortlessly! Chinese scientists have developed flavorless, fat-trapping microbeads made from green tea ...

Discover why Hims & Hers Health's subscriber growth, profitability, and telehealth expansion make it a strong buy with a ...

The Dow Jones and S&P 500 jumped Friday to record highs on Fed chief Jerome Powell's dovish Jackson Hole speech.

The FDA cleared the first glucose monitoring system specifically designed for weight management from Signos, providing a new ...

Dr. Sterling Elliott, Clinical pharmacist at Northwestern Medicine and assistant professor of orthopaedics at Feinberg School ...